Literature DB >> 23293557

Cutaneous malignancies in patients with inflammatory bowel disease.

Millie D Long1.   

Abstract

Entities:  

Year:  2012        PMID： 23293557      PMCID： PMC3533223     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

Review 1.  Nonmelanoma skin cancer in inflammatory bowel disease: a review.

Authors:  Millie D Long; Michael D Kappelman; Clare A Pipkin
Journal:  Inflamm Bowel Dis       Date:  2010-11-04       Impact factor: 5.325

2.  Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.

Authors:  Laurent Peyrin-Biroulet; Kiarash Khosrotehrani; Fabrice Carrat; Anne-Marie Bouvier; Jean-Baptiste Chevaux; Tabassome Simon; Frank Carbonnel; Jean-Frédéric Colombel; Jean-Louis Dupas; Philippe Godeberge; Jean-Pierre Hugot; Marc Lémann; Stéphane Nahon; Jean-Marc Sabaté; Gilbert Tucat; Laurent Beaugerie
Journal:  Gastroenterology       Date:  2011-06-25       Impact factor: 22.682

3.  Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease.

Authors:  Harminder Singh; Zoann Nugent; Alain A Demers; Charles N Bernstein
Journal:  Gastroenterology       Date:  2011-07-30       Impact factor: 22.682

4.  Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study.

Authors:  Mashiko Setshedi; David Epstein; Trevor A Winter; Landon Myer; Gillian Watermeyer; Richard Hift
Journal:  J Gastroenterol Hepatol       Date:  2012-02       Impact factor: 4.029

5.  Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease.

Authors:  Millie D Long; Hans H Herfarth; Clare A Pipkin; Carol Q Porter; Robert S Sandler; Michael D Kappelman
Journal:  Clin Gastroenterol Hepatol       Date:  2010-01-16       Impact factor: 11.382

6.  Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.

Authors:  Millie D Long; Christopher F Martin; Clare A Pipkin; Hans H Herfarth; Robert S Sandler; Michael D Kappelman
Journal:  Gastroenterology       Date:  2012-05-11       Impact factor: 22.682
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.